Study Evaluating Ways of Preventing Patients From Being Awake During High-Risk Surgery and Anesthesia

July 20, 2012 updated by: Michael Avidan, Washington University School of Medicine

B-Unaware Study: Comparison of BIS-guided Anesthesia With End-Tidal Volatile-Guided Anesthesia to Decrease The Incidence of Awareness During High-Risk Surgery

The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.

Study Overview

Detailed Description

General anesthesia is a state of drug-induced unconsciousness, during which patients should neither perceive nor recall noxious stimuli. Many patients facing surgery dread the prospect of being awake, in pain and unable to move owing to inadequate general anesthesia. A large multi-center study in the USA showed that, despite modern anesthesia techniques, the overall incidence of awareness or conscious recall remains about 0.1-0.2%. For high-risk (for awareness) surgery, such as cardiac surgery, trauma surgery and obstetric surgery, the incidence of conscious recall approaches 1%. This can lead to extreme anxiety and even posttraumatic stress disorder. Several monitors, including the Bispectral Index (BIS), which is based on processed electroencephalographic information, have been developed in an attempt to monitor depth of anesthesia. A recent landmark study suggested that harnessing the information provided by the BIS monitor decreases the incidence of explicit recall during high-risk surgical procedures from almost 1% to 0.1%. The possible impact of this study is enormous. The American Society of Anesthesiologists and the American Association of Nurse Anesthetists do not currently consider neurological monitors an essential part of routine anesthesia care. Increasingly, members of the anesthetic community are suggesting that for every patient undergoing general anesthesia, especially for procedures where the risk of awareness is considered higher, a neurological monitor, such as the BIS monitor, should be routinely applied.

Explicit recall under general anesthesia is a major concern among members of the public and has even been featured on the popular Oprah Winfrey Show. Several patients presenting for surgery at Barnes Jewish Hospital have questioned whether the anesthesia provider would be using a BIS monitor to "prevent awareness". Excluding the cost of the BIS monitor itself, the cost to use BIS is $17.50 for the disposable strip. If this monitor was to be used for every anesthetic administered at Barnes Jewish Hospital, this might translate to an annual cost of about $500,000. Explicit recall, especially when patients have been aware and unable to move, is a serious complication that frequently precipitates posttraumatic stress disorder. If indeed the BIS monitor does decrease the incidence of explicit recall, this could translate into a cost effective and more importantly clinically imperative intervention. Currently BIS monitors, or similar alternatives, are not used routinely to monitor depth of general anesthesia at Barnes Jewish Hospital.

However, there are several concerns regarding the studies that have been conducted using the BIS monitor. There have been no parameters guiding administration of anesthesia in the control groups. BIS data have not been collected for patients in control groups, which prevents retrospective analysis and assessment of the true sensitivity, specificity, positive and negative predictive values of the BIS recordings. Most of the studies have been funded by the manufacturer of the device, which introduces a potential conflict of interest and investigator bias. In view of the current pressure to adopt BIS monitoring or an equivalent into the standard of anesthesia care, it is essential to conduct a study to address some of the concerns. The hypothesis of this proposed study is that an anesthetic algorithm can be designed for high-risk surgical patients such that the incidence of awareness will be equivalent to or lower than that in a group where anesthesia depth is guided by the BIS monitor.

Study Type

Interventional

Enrollment (Actual)

2000

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • St Louis, Missouri, United States, 63110
        • Barnes-Jewish Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

MUST HAVE:

General Anesthesia with volatile anesthetic

PATIENT CHARACTERISTICS

Major Criteria (any 1 of the following:)

  1. Medications - anticonvulsants, abuse of opiates, benzodiazepines, cocaine
  2. EF<40%
  3. Prior history of awareness (recall)
  4. History of difficult intubation or anticipated difficult intubation
  5. ASA IV or V status
  6. Aortic stenosis
  7. End stage lung disease
  8. Marginal exercise tolerance not secondary to musculoskeletal dysfunction
  9. Pulmonary hypertension
  10. Daily alcohol consumption

Minor Criteria (any 2 of the following)

  1. Beta blockers
  2. COPD
  3. Moderate exercise tolerance not secondary to musculoskeletal dysfunction
  4. Smokes ≥2 packs per day
  5. Morbid obesity BMI>30 -

Exclusion Criteria:

  1. Surgical procedure that prevents the use of the BIS (e.g surgery of forehead)
  2. Patient positioning prevents use of the BIS
  3. Surgery with wake-up test.
  4. Less than 18 years of age
  5. Vulnerable populations, such as those with dementia and those unable to provide informed consent.
  6. Stroke with residual neurological deficits

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: BIS Monitor guided algorithm
BIS guided algorithm (BIS target 40 to 60) during anesthesia. Alarms when BIS is outside this range.
BIS guided algorithm (BIS target 40 to 60) during anesthesia. Alarms when BIS is outside this range.
ACTIVE_COMPARATOR: Volatile anesthetic guided algorithm
Volatile anesthetic guided algorithm. Target anesthetic concentration 0.7 to 1.3 minimum alveolar concentration during anesthesia. Alarms when anesthetic concentration not in this range.
Volatile anesthetic guided algorithm. Target anesthetic concentration 0.7 to 1.3 minimum alveolar concentration during anesthesia. Alarms when anesthetic concentration not in this range.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The incidence of explicit recall of events during the surgical and anesthetic periods.
Time Frame: 30 days
30 days

Secondary Outcome Measures

Outcome Measure
Time Frame
1 Anesthetic concentrations & BIS values in each group.
Time Frame: 1 day
1 day
2 Implicit memory (number).
Time Frame: 30 days
30 days
3 Dreaming.
Time Frame: 30 days
30 days
4 One-year mortality (and "anesthetic depth").
Time Frame: 1 year
1 year
5 Relation of assessment to BIS value.
Time Frame: 30 days
30 days
6 Relation of events (e.g. movement) to BIS & ETAG.
Time Frame: 1 day
1 day
7 Relation of EMG to BIS.
Time Frame: 1 day
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Beth Burnside, Washington University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2005

Primary Completion (ACTUAL)

October 1, 2006

Study Registration Dates

First Submitted

January 20, 2006

First Submitted That Met QC Criteria

January 20, 2006

First Posted (ESTIMATE)

January 24, 2006

Study Record Updates

Last Update Posted (ESTIMATE)

July 23, 2012

Last Update Submitted That Met QC Criteria

July 20, 2012

Last Verified

July 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 04-1112

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Explicit Recall of Intra-operative Events

Clinical Trials on BIS Monitor guided algorithm

3
Subscribe